Optoacoustic Ultrasound May Help Radiologists Improve Specificity Of Breast Imaging, Study Suggests.

Friday, July 6, 2018

The Radiology Business Journal (7/6, Walter) reported researchers found that “optoacoustic ultrasound can help radiologists improve the specificity of breast imaging without leading to a loss in sensitivity.” The findings were published in the American Journal of Roentgenology.

Limiting Breast Cancer Screening To Women At Higher Levels Of Risk For The Disease Could Improve Cost-Effectiveness, Reduce Overdiagnosis, Research Indicates.

Thursday, July 5, 2018

STAT (7/5, Faber) reports a study published in JAMA Oncology “suggests that women might benefit from individualized approaches to mammograms rather than from universal guidelines.” Researchers revealed that, “As fewer women were screened, both the number of overdiagnosed breast cancer decreased, as did the number of breast cancer deaths prevented by screening,” and that the new method “might even be more cost-effective.” Also covering the story are Medscape (7/5, Mulcahy, Subscription Publication), the Radiology Business Journal (7/5, Walter), Aunt Minnie (7/5, Ward).

ACR’s Commission On Breast Imaging Sends Letter To Physician Data Query Editorial Board Objecting To Certain Breast Cancer Screening PDQ Language.

Tuesday, July 3, 2018

The Radiology Business Journal (7/3, Walter) reported the American College of Radiology Commission on Breast Imaging “sent a letter to the Physician Data Query (PDQ) Editorial Board objecting to specific language included in the recently updated Breast Cancer Screening PDQ.” Dana H. Smetherman, MD, MPH, MBA, chair of the ACR Commission on Breast Imaging, and Kelly Biggs, MD, chair of the ACR Committee on Government Relations, signed the two-page letter. Smetherman and Biggs ended the letter saying, “We would welcome the opportunity to discuss this matter with you in more detail and to provide additional information or respond to specific questions you may have.”

Clinical Trial To Discern Whether Women With HER2 Breast Cancer Can Do Without Radiation.

Monday, July 2, 2018

HealthImaging (7/2, O'Connor) reports on a clinical trial being started at the University of Kansas Cancer Center, in which researchers are “recruiting post-menopausal women at least 50 years old who are in the early stages of human epidermal growth factor receptor 2 (HER2) positive invasive ductal carcinoma and also have clear lymph nodes.” The patients will decide whether to join “the intervention group (no radiation) or the control group,” who will receive radiation. Melissa Mitchell, MD, PhD, who is leading the trial, said, “The treatment drugs have just become so effective that it made us think that maybe we could scale back and spare patients the side effects of radiation.”

Study Finds CAD-enhanced Synthetic Mammography Improved Diagnosis.

Monday, July 2, 2018

Radiology Business Journal (7/2, Walter) reports on a study published in Clinical Radiology finding that “combining digital breast tomosynthesis (DBT) and standard 2D full-field digital mammography (FFDM) gives radiologists a powerful tool for detecting deadly breast lesions,” though it also exposes “the patient to much more radiation.” The study “compared the diagnostic performance of CAD-enhanced synthetic mammography, synthetic mammography and FFDM” and included “68 cases where all three mammogram types were available.” The researchers found that CAD-enhanced synthetic mammogram showed “significantly improved” diagnosis, compared to the standard synthetic mammogram and FFDM mammogram.